A detailed history of Avidity Partners Management LP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 2,133,872 shares of TERN stock, worth $12.4 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
2,133,872
Holding current value
$12.4 Million
% of portfolio
1.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $13.8 Million - $23 Million
2,133,872 New
2,133,872 $17.8 Million
Q2 2021

Aug 16, 2021

SELL
$12.26 - $22.0 $4.9 Million - $8.8 Million
-400,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$17.13 - $27.25 $6.85 Million - $10.9 Million
400,000 New
400,000 $8.8 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.